JOAN GILLIS: Open Payments
NPI 1922272541 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 57 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $585 · 2025 $1,377
Food & beverage: $1,297Education: $80
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 11 | $285 |
| Viatris Specialty LLC | 7 | $228 |
| Regeneron Healthcare Solutions, Inc. | 8 | $201 |
| GlaxoSmithKline, LLC. | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Amgen Inc. | 4 | $66 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $63 |
| United Therapeutics Corporation | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
Products named: Ohtuvayre, YUPELRI, DUPIXENT, NUCALA, TEZSPIRE, LUMRYZ, AIRSUPRA, BREZTRI.
Industry payments across NC — which companies pay providers there.
